AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
Factors to Note Sales of AstraZeneca's key medicines, mainly cancer drugs — Lynparza, Tagrisso and Imfinzi — and diabetes medicine Farxiga, are expected to have driven the company's top line in the first quarter, backed by strong demand trends. Price reductions of some drugs in emerging markets hurt product sales in the fourth quarter, a trend that is likely to have continued in the first quarter of 2024. Approvals for new indications boosted sales growth of some key drugs like Imfinzi and Farxiga. The Zacks Consensus Estimate for Tagrisso, Farxiga and Imfinzi is pegged at $1.51 billion, $1.63 billion and $1.18 billion, respectively. Our model estimates for Tagrisso, Farxiga and Imfinzi are $1.55 billion, $1.57 billion and $1.2 billion, respectively. In the third and fourth quarters of 2023, sales of Lynparza were somewhat hurt by declining use of PARP inhibitors class of drugs and some label restrictions for use in second-line ovarian cancer in the United States, a trend t
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca reports positive interim data from mantle cell lymphoma trial [Yahoo! Finance]Yahoo! Finance
- Box Sets Date to Announce First Quarter Fiscal 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Matan's Lease with AstraZeneca at 700 Progress Way Awarded 'Best Maryland Lease of 2023' by the Washington Business Journal [Yahoo! Finance]Yahoo! Finance
- The World Market for Ovarian Cancer Drugs to 2030: Breakthroughs in Combination Drug Therapy Transforming Standards of Care [Yahoo! Finance]Yahoo! Finance
- Novartis to Buy Mariana Oncology, Paying $1 Billion Upfront [BNN Bloomberg (Canada)]BNN Bloomberg
AZN
Sec Filings
- 5/2/24 - Form 6-K
- 5/1/24 - Form 6-K
- 4/29/24 - Form 6-K
- AZN's page on the SEC website